Advertisement

Ads Placeholder
Loading...

Silence Therapeutics plc

SLNCFPNK
Healthcare
Biotechnology
$2.00
$0.00(0.00%)
U.S. Market opens in 4h 55m

SLNCF News Today: Stay Updated with the Latest Silence Therapeutics plc News in Real Time

Find SLNCF news now at Meyka AI. Stay informed with the latest Silence Therapeutics plc stocks updates, including price news, market analysis, and expert insights.

Vimy Ridge Day: April 10 Canada Flags Return to Full-mast After Observance
📅 in about 5 hours

Vimy Ridge Day: April 10 Canada Flags Return to Full-mast After Observance

Vimy Ridge Day sees Canada’s flags at half‑mast on April 9, returning to full‑mast on April 10. What it means, how communities marked it, and investor takeaways.

Read more
April 10: Carolyn Creswell Ordeal Puts Founder Risk in Focus
📅 22 minutes ago

April 10: Carolyn Creswell Ordeal Puts Founder Risk in Focus

Carolyn Creswell incident spotlights key person risk for founder-led FMCG in Australia. We outline governance, crisis management steps, and investor signals to protect value.

Read more
09 Apr 2026 PRFN.SW Kinarus (SIX) -8.12% on 2.94M vol: PRFN.SW stock at CHF0.0362 support
📅 7 hours ago

09 Apr 2026 PRFN.SW Kinarus (SIX) -8.12% on 2.94M vol: PRFN.SW stock at CHF0.0362 support

PRFN.SW stock fell to CHF0.0362 on 09 Apr 2026 with 2.94M shares traded; intraday drivers, Meyka AI grade and forecast included

Read more
BTIG Maintains Buy on Aldeyra Therapeutics (ALDX) March 2026
📅 17 hours ago

BTIG Maintains Buy on Aldeyra Therapeutics (ALDX) March 2026

BTIG maintained Buy on Aldeyra; ALDX analyst rating points to regulatory clarity in 90 days

Read more
LDO.MI Stock Today, April 9: CEO Ouster Looms as Rome Sets Slate
📅 17 hours ago

LDO.MI Stock Today, April 9: CEO Ouster Looms as Rome Sets Slate

Leonardo CEO replacement concerns hit LDO.MI as Rome readies its board slate. We break down price risks, strategy stakes, and what Swiss investors should watch now.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
📅 17 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial rating, citing scarcity value in competitive drug market.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
📅 19 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates coverage of Summit Therapeutics (SMMT) with Buy rating, citing scarcity value in competitive drug development landscape.

Read more
€0.04 intraday: MBH Corp (M8H.DE XETRA) 09 Apr 2026 risks & outlook
📅 20 hours ago

€0.04 intraday: MBH Corp (M8H.DE XETRA) 09 Apr 2026 risks & outlook

M8H.DE stock plunges intraday to €0.04 on 09 Apr 2026; read our intraday analysis, Meyka grade and €0.08 forecast

Read more
CHM.AX falls 50.00% to A$0.001 on ASX after hours 09 Apr 2026: key targets
📅 20 hours ago

CHM.AX falls 50.00% to A$0.001 on ASX after hours 09 Apr 2026: key targets

CHM.AX stock plunges 50.00% after hours on 09 Apr 2026 to A$0.001; analysis, Meyka AI grade and price targets

Read more

SLNCF News FAQ